SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 1997 KAMAN CORPORATION (Exact name of issuer as specified in its charter) Connecticut 0-1093 06-0613548 (State of (Commission (I.R.S. Incorporation) File Number) Employer Identification No.) 1332 Blue Hills Avenue Bloomfield, CT 06002 (Address of principal executive offices) Registrant's telephone number, including area code: (860) 243-7100 Not Applicable (Former name or former address, if changes since last report) Item 5. Other Events. On November 14, 1997, the Company announced that it had entered into a definitive agreement with ITT Industries, Inc. for the sale of Kaman Sciences Corporation, the Company's defense related sciences subsidiary, to ITT Industries for $135 million in cash. The transaction has been approved by the boards of directors of both companies and is subject to customary conditions, including the receipt of all required regulatory approvals. The Company expects to complete the transaction by year end. Item 7. Financial Statements and Exhibits (a) Financial Statements of Business Acquired. Not Applicable. (b) Pro Forma Financial Information. Not Applicable. (c) Exhibits. The following document is filed as an Exhibit to this Report: Exhibit 99 - Press Release of the Company, dated November 14, 1997. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf, by the undersigned, thereunto duly authorized. KAMAN CORPORATION By: Robert M. Garneau Executive Vice President and Chief Financial Officer Dated: November 17, 1997 EXHIBIT INDEX Exhibit Description 99 Press Release of the Company, dated November 14, 1997